Original Article: Autoimmunity and Clinical Immunology

T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19

Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022

---

Comparing the levels of CTLA-4 dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency

Catak, M.C., Akcam, B., Bilgic Eltan, S., et al. Allergy. First published: 01 May 2022

---

Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study

Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022

---

Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures

Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022

---

Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants

Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022

---

Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization

Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022

---

Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination

Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022

---

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study

Horn, M.P., Jonsdottir, H.R., Brigger, D., et al. Allergy. First published: 05 January 2022

---

Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses

Hein, S, Herrlein, M-L, Mhedhbi, I, et al. Allergy.First published: 25 November 2021

---

Patients with systemic sclerosis show phenotypic and functional defects in neutrophils

Impellizzieri, D, Egholm, C, Valaperti, A, Distler, O, Boyman, O. Allergy.First published: 01 September 2021

---

Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes

Gattinger, P., Niespodziana, K., Stiasny, K., et al. Allergy.First published: 28 August 2021

---

Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency

Kolukisa, B., Baser, D., Akcam, B., et al. Allergy.First published: 20 July 2021

---

Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study

Blain, H., Tuaillon, E., Gamon, L., et al. Allergy.First published: 19 July 2021

---

Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19

Adamo, S., Chevrier, S., Cervia, C., et al. Allergy.2021; 76: 2866-2881

---

Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature

Galdiero, M.R., Maio, F., Arcoleo, F., et al. Allergy.2021; 76: 2189-2200

---

Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19

Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., et al. Allergy. 2021; 76: 1846-1858

---

Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study

Brigger, D, Horn, MP, Pennington, LF, et al. Allergy. 2021; 76: 853– 865

---

Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections

Lei, Q, Li, Y, Hou, H-Y, et al. Allergy. 2021; 76: 551– 561

---

ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients

Eken, A, Cansever, M, Okus, FZ, et al. Allergy. 2020; 75: 921– 932

---

Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients

Jacob, M, Bin Khalaf, D, Alhissi, S, et al. Allergy. 2019; 74: 370– 379

---